CliffBio
small molecule

COTEMPLA XR-ODT

METHYLPHENIDATE

Loss of exclusivityJanuary 2038latest FDA-listed patent expiry
CompanyNEOS →View the full company profile on CliffBio

Drug detail

Brand nameCOTEMPLA XR-ODT
Active ingredientMETHYLPHENIDATE
Strength25.9MG
Dosage formTABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJune 2017
Marketing statusRX

Listed patents

PatentExpiresType
11166947January 2038use U-3299
9072680June 2032product
9089496June 2032product
8840924June 2026product

More from NEOS

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

COTEMPLA XR-ODT patent cliff — loss of exclusivity January 2038 | CliffBio